Literature DB >> 7679585

Acute myeloid leukaemia in the elderly: biology and treatment.

P R Johnson1, J A Liu Yin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679585     DOI： 10.1111/j.1365-2141.1993.tb04622.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

2.  Prognosis of infections in elderly patients with haematological diseases.

Authors:  F Rossini
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

3.  A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.

Authors:  Dianna S Howard; Jane Liesveld; Gordon L Phillips; John Hayslip; Heidi Weiss; Craig T Jordan; Monica L Guzman
Journal:  Leuk Res       Date:  2013-09-08       Impact factor: 3.156

4.  Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.

Authors:  Carla S Wilson; George S Davidson; Shawn B Martin; Erik Andries; Jeffrey Potter; Richard Harvey; Kerem Ar; Yuexian Xu; Kenneth J Kopecky; Donna P Ankerst; Holly Gundacker; Marilyn L Slovak; Monica Mosquera-Caro; I-Ming Chen; Derek L Stirewalt; Maurice Murphy; Frederick A Schultz; Huining Kang; Xuefei Wang; Jerald P Radich; Frederick R Appelbaum; Susan R Atlas; John Godwin; Cheryl L Willman
Journal:  Blood       Date:  2006-04-04       Impact factor: 22.113

Review 5.  Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.

Authors:  C J Dunn; K L Goa
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

6.  Factors associated with transfusion requirements during treatment for acute myelogenous leukemia.

Authors:  G Favre; M Fopp; J Gmür; A Tichelli; M F Fey; A Tobler; E Schatzmann; A Gratwohl
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

Review 7.  Treatment concepts for elderly patients with acute myeloid leukemia.

Authors:  Wolfgang R Sperr; Alexander W Hauswirth; Friedrich Wimazal; Paul Knöbl; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

8.  The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.

Authors:  Akira Horikoshi; Kazuhiro Takei; Yoshifumi Hosokawa; Shigemasa Sawada
Journal:  Int J Hematol       Date:  2008-01-30       Impact factor: 2.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.